Publication Plan 2020 - Spherix Global InsightsUS Headquarters 707 Eagleview Blvd. Suite 305 Exton,...
7
A passion for turning high quality, independent research insights into actionable, commercial intelligence. Why Spherix Global Insights? Our independent reports are designed, developed, and fielded by Spherix. We aspire to be the intelligence provider of choice in the select therapy areas we cover and therefore we invest in our client relationships as long-term partnerships. Our intelligence teams have extensive experience in market research, data analysis, pharma brand management, and strategic marketing. We understand the business context of the research because our leadership has been in the decision-maker’s seat before and understands the challenges and missed opportunities caused by data you can’t be truly confident in. We are hyper-focused on just three specialty areas because we believe in mastery. This ensures we bring a deep understanding of both the clinical aspects and market dynamics for the diseases we work with. Working with our KOL advisory boards in each of our focus areas, we keep our finger on the pulse of the key clinical and commercial market issues and drivers. Our experts also provide input and interpretation of the findings to finely tune the final reports. Our research is conducted in collaboration with our proprietary networks of engaged physicians, ancillary healthcare professionals and patients. By cultivating our own proprietary networks, we can control the quality of the respondents and ensure that you are getting insights from a group representative of your customer base. At Spherix, the report is only part of the deliverable. Our insights are customized to your business needs and we thrive on delivering not just data, but context. Invest In Intelligence That Delivers. For more information about Spherix Global Insights and our services, contact us at [email protected] or call (484) 879-4284. Visit our website: www.spherixglobalinsights.com Publication Plan 2020
Transcript of Publication Plan 2020 - Spherix Global InsightsUS Headquarters 707 Eagleview Blvd. Suite 305 Exton,...
A passion for turning high quality, independent research insights into actionable,
commercial intelligence.
Why Spherix Global Insights?
Our independent reports are designed, developed, and fielded by Spherix.
We aspire to be the intelligence provider of choice in the select therapy areas we cover and
therefore we invest in our client relationships as long-term partnerships. Our intelligence teams
have extensive experience in market research, data analysis, pharma brand management, and
strategic marketing. We understand the business context of the research because our leadership
has been in the decision-maker’s seat before and understands the challenges and missed
opportunities caused by data you can’t be truly confident in.
We are hyper-focused on just three specialty areas because we believe in mastery. This ensures
we bring a deep understanding of both the clinical aspects and market dynamics for the diseases
we work with.
Working with our KOL advisory boards in each of our focus areas, we keep our finger on the
pulse of the key clinical and commercial market issues and drivers. Our experts also provide
input and interpretation of the findings to finely tune the final reports.
Our research is conducted in collaboration with our proprietary networks of engaged physicians,
ancillary healthcare professionals and patients. By cultivating our own proprietary networks, we
can control the quality of the respondents and ensure that you are getting insights from a group
representative of your customer base.
At Spherix, the report is only part of the deliverable. Our insights are customized to your business
needs and we thrive on delivering not just data, but context.
Invest In Intelligence That Delivers.
For more information about Spherix Global Insights and our services, contact us at
[email protected] or call (484) 879-4284.
Visit our website: www.spherixglobalinsights.com
Publication Plan 2020
RealTime Dynamix™ is an independent service providing strategic guidance
through rapid and comprehensive reports, which include market trending,
launch tracking, and a fresh infusion of unique content with each wave.
Immunology Services
US Headquarters
707 Eagleview Blvd. Suite 305
Exton, PA 19341
Service Title
Report
Frequency 2016 2017 2018 2019 2020
• RealTime Dynamix: Ankylosing Spondylitis & Non-
Radiographic Axial Spondyloarthritis US
Bi-annual
• RealTime Dynamix: Atopic Dermatitis US Quarterly
• RealTime Dynamix: Atopic Dermatitis EU Bi-annual
• RealTime Dynamix: Eosinophilic Esophagitis US Bi-annual
• RealTime Dynamix: Inflammatory Bowel Disease US Quarterly
• RealTime Dynamix: Inflammatory Bowel Disease EU Bi-annual
• RealTime Dynamix: Psoriasis US Quarterly
• RealTime Dynamix: Psoriasis EU Bi-annual
• RealTime Dynamix: Psoriatic Arthritis US Quarterly
• RealTime Dynamix: Psoriatic Arthritis EU Bi-annual
• RealTime Dynamix: Rheumatoid Arthritis US Quarterly
• RealTime Dynamix: Rheumatoid Arthritis EU Bi-annual
Service Title
Report
Frequency 2016 2017 2018 2019 2020
• RealWorld Dynamix: Biologic/Small Molecule New
Starts in IBD US
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in IBD US
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in IBD EU
Annual
Contact
(484) 879-4284
RealWorld Dynamix™ is an independent, data-driven service unmasking real
patient management patterns through annual reports based on chart audits of
~1,000 patients. The report uncovers the “why” behind treatment decisions,
includes year over year trending to quantify key aspects of market evolution,
and integrates specialists’ attitudinal & demographic data to highlight
differences between stated and actual treatment patterns.
US Headquarters
707 Eagleview Blvd. Suite 305
Exton, PA 19341
Contact
(484) 879-4284
Service Title
Report
Frequency 2016 2017 2018 2019 2020
• RealWorld Dynamix: Biologic/Small Molecule New
Starts in Psoriasis US
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in Psoriasis US
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in Psoriasis EU
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in PsA US
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in PsA EU
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in RA US
Annual
• RealWorld Dynamix: Biologic/Small Molecule
Switching in RA EU
Annual
• RealWorld Dynamix: Moderate-to-Severe AD US Annual
• RealWorld Dynamix: Moderate-to-Severe AD EU Annual
• RealWorld Dynamix: Systemic Lupus Nephritis US Annual
Service Title Report Frequency 2019 2020
• Market Dynamix: Hidradenitis Suppurativa US Annual
• Market Dynamix: Hidradenitis Suppurativa EU Annual
• Market Dynamix: Lupus & Lupus Nephritis US Annual
• Market Dynamix: Lupus & Lupus Nephritis EU Annual
Market Dynamix™ is an independent service that utilizes a combination of qualitative
and quantitative market research to explore the future dynamics of evolving healthcare
treatment paradigms. The qualitative analysis is fueled by interviews with the leading
international opinion leaders. The quantitative portion leverages our proprietary network
of specialists “in the trenches” for sizing the market and to understand current
perceptions, gaps in product awareness, and unmet needs.
RealTime Dynamix™ is an independent service providing strategic guidance
through rapid and comprehensive reports, which include market trending,
launch tracking, and a fresh infusion of unique content with each wave.
US Headquarters
707 Eagleview Blvd. Suite 305
Exton, PA 19341
Contact
(484) 879-4284
Nephrology Services
Service Title
Report
Frequency 2015 2016 2017 2018 2019 2020
• RealTime Dynamix: Bone and Mineral Metabolism US Quarterly
• RealTime Dynamix: Hyperkalemia (Cardiology) US Quarterly
• RealTime Dynamix: Hyperkalemia (Nephrology) US Quarterly
• RealTime Dynamix: Hyperkalemia EU Bi-annual
• RealTime Dynamix: Polycystic Kidney Disease US Quarterly
• RealTime Dynamix: Renal Anemia US Quarterly
• RealTime Dynamix: Renal Anemia EU Bi-annual
• RealTime Dynamix: Renal Dietitians US Bi-annual
Service Title
Report
Frequency 2015 2016 2017 2018 2019 2020
• RealWorld Dynamix: Chronic Kidney Disease US Annual
• RealWorld Dynamix: CKD (PCP Perspective) US Annual
• RealWorld Dynamix: CKD-MBD* US in CKD-ND Annual
• RealWorld Dynamix: CKD-MBD* in Dialysis US Annual
• RealWorld Dynamix: CKD Non-Dialysis US Annual
• RealWorld Dynamix: Dialysis US Annual
• RealWorld Dynamix: Hyperkalemia US Annual
• RealWorld Dynamix: Home Modalities US Annual
• RealWorld Dynamix: Incident Dialysis US Annual
• RealWorld Dynamix: Lupus Nephritis US Annual
• RealWorld Dynamix: Renal Anemia US in CKD-ND Annual
• RealWorld Dynamix: Renal Anemia in Dialysis US Annual
RealWorld Dynamix™ is an independent, data-driven service unmasking real
patient management patterns through annual reports based on chart audits of
~1,000 patients. The report uncovers the “why” behind treatment decisions,
includes year over year trending to quantify key aspects of market evolution,
and integrates specialists’ attitudinal & demographic data to highlight
differences between stated and actual treatment patterns.
* Bone and Mineral Metabolism
US Headquarters
707 Eagleview Blvd. Suite 305
Exton, PA 19341
Contact
(484) 879-4284
Service Title Report Frequency 2018 2019 2020
• Market Dynamix: Cross-Specialty Anemia Management US Annual
• Market Dynamix: Diabetic Nephropathy US Annual
• Market Dynamix: FSGS US Annual
• Market Dynamix: Glomerular Diseases US Annual
• Market Dynamix: IgA Nephropathy US Annual
• Market Dynamix: Metabolic Acidosis US Annual
• Market Dynamix: Lupus & Lupus Nephritis US Annual
• Market Dynamix: Lupus & Lupus Nephritis EU Annual
• Market Dynamix: Uremic Pruritus US Annual
Market Dynamix™ is an independent service that utilizes a combination of qualitative
and quantitative market research to explore the future dynamics of evolving healthcare
treatment paradigms. The qualitative analysis is fueled by interviews with the leading
international opinion leaders. The quantitative portion leverages our proprietary network
of specialists “in the trenches” for sizing the market and to understand current
perceptions, gaps in product awareness, and unmet needs.
Fellowship Dynamix™ is an independent service that captures opinions and
perspectives of nephrologists in training programs and those in practice for less
than five years in order to better understand the motivations, understandings,
knowledge gaps, and interest of tomorrow’s specialists.
Service Title Report Frequency 2019 2020
• Fellowship Dynamix: Renal Fellows (US) Annual
Pipeline Dynamix™ is a comprehensive report highlighting the market opportunity
for the ten most interesting renal pipeline products that are targets for acquisition or
partnership. The report combines KOL/general nephrologist qualitative interviews
and a survey to assess relative unmet need. Which assets make the cut?
Service Title Report Frequency 2020
• Pipeline Dynamix: Nephrology Products (US) Annual
RealTime Dynamix™ is an independent service providing strategic guidance
through rapid and comprehensive reports, which include market trending,
launch tracking, and a fresh infusion of unique content with each wave.
US Headquarters
707 Eagleview Blvd. Suite 305
Exton, PA 19341
Service Title
Report
Frequency 2016 2017 2018 2019 2020
• RealTime Dynamix: Multiple Sclerosis US Quarterly
• RealTime Dynamix: Multiple Sclerosis EU Bi-annual
• RealTime Dynamix: Multiple Sclerosis Canada Bi-annual
• RealTime Dynamix: Migraine Prevention US Quarterly
• RealTime Dynamix: Migraine Prevention EU Bi-annual
Service Title
Report
Frequency 2016 2017 2018 2019 2020
• RealWorld Dynamix: DMT New Starts in Multiple
Sclerosis US
Annual
• RealWorld Dynamix: DMT Switching in Multiple
Sclerosis US
Annual
• RealWorld Dynamix: DMT Switching in Multiple
Sclerosis EU
Annual
• RealWorld Dynamix: Progressive Forms of Multiple
Sclerosis US
Annual
• RealWorld Dynamix: Progressive Forms of Multiple
Sclerosis EU
Annual
• RealWorld Dynamix: Migraine Prevention US Annual
• RealWorld Dynamix: Migraine Prevention EU Annual
Contact
(484) 879-4284
RealWorld Dynamix™ is an independent, data-driven service unmasking real
patient management patterns through annual reports based on chart audits of
~1,000 patients. The report uncovers the “why” behind treatment decisions,
includes year over year trending to quantify key aspects of market evolution,
and integrates specialists’ attitudinal & demographic data to highlight
differences between stated and actual treatment patterns.
Neurology Services
US Headquarters
707 Eagleview Blvd. Suite 305
Exton, PA 19341
Service Title Report Frequency 2019 2020
• RealTime Dynamix: Multiple Myeloma US Quarterly
• RealTime Dynamix: Multiple Myeloma EU Bi-annual
Contact
(484) 879-4284
Service Title Report Frequency 2020
• RealWorld Dynamix: Multiple Myeloma US Annual
Oncology Services
RealTime Dynamix™ is an independent service providing strategic guidance
through rapid and comprehensive reports, which include market trending,
launch tracking, and a fresh infusion of unique content with each wave.
RealWorld Dynamix™ is an independent, data-driven service unmasking real
patient management patterns through annual reports based on chart audits of
~1,000 patients. The report uncovers the “why” behind treatment decisions,
includes year over year trending to quantify key aspects of market evolution,
and integrates specialists’ attitudinal & demographic data to highlight
differences between stated and actual treatment patterns.
